MeSH tree: D12.776.124.125
Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to deliver gene therapy for patients with severe hemophilia A. The study presents a potential alternative ...
In the not-so-distant past, doctors treated strokes in an after-the-fact way. A stroke did its damage, and then—if the patient survived—a rehabilitation team stepped in to address the stroke's effects.
Nov 21, 2024
0
21
University of B.C. researchers have developed a coating that could make medical devices safer for millions of patients, reducing the risks associated with blood clots and dangerous bleeding. The work has been published in ...
Nov 12, 2024
0
93
It's been more than three decades, but still there are only two treatments for a stroke: either rapid use of a clot-busting medication called tPA or surgical removal of a clot from the brain with mechanical thrombectomy. ...
Oct 28, 2024
0
97
In healthy rodent brains, newborn neurons are constantly generated in the stem cell niche, known as the subventricular zone (SVZ). These cells might help to repair a brain that has been damaged by disorders of the central ...
Oct 24, 2024
0
52
A simple blood test could help doctors identify women in labor who are at risk for preeclampsia—a leading cause of maternal death—and take precautions to prevent it, according to research presented at the ANESTHESIOLOGY 2024 ...
Oct 19, 2024
0
30
For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published ...
Oct 17, 2024
0
18
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, ...
Oct 16, 2024
0
23
The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with ...
Oct 15, 2024
0
26
Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process ...
Oct 2, 2024
0
33
